Technical Analysis for ELOX - Eloxx Pharmaceuticals Inc
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | N/A | Down | Down |
| See historical ELOX trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Slingshot Bearish | Bearish Swing Setup | 0.00% | |
| Narrow Range Bar | Range Contraction | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Gapped Up | Strength | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| New 52 Week Closing Low | Bearish | 16.00% | |
| Volume Surge | Other | 16.00% | |
| Narrow Range Bar | Range Contraction | 16.00% | |
| NR7 | Range Contraction | 16.00% | |
| NR7-2 | Range Contraction | 16.00% |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Sector: Healthcare
- Industry: Biotechnology
Eloxx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel therapeutics for the treatment of rare and ultra-rare premature stop codon diseases. Its lead program is ELX-02, which is in Phase I clinical trial, which focuses on the treatment of cystic fibrosis and cystinosis patients with diagnosed nonsense mutations. The company was founded in 2013 and is headquartered in Waltham, Massachusetts.
Medical Specialties RTT Branches Of Biology Biopharmaceutical Cystic Fibrosis Treatment Of Cystic Fibrosis Channelopathies Cystinosis
Medical Specialties RTT Branches Of Biology Biopharmaceutical Cystic Fibrosis Treatment Of Cystic Fibrosis Channelopathies Cystinosis
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 19.5 |
| 52 Week Low | 4.39 |
| Average Volume | 40,955 |
| 200-Day Moving Average | 0.0000 |
| 50-Day Moving Average | 10.2800 |
| 20-Day Moving Average | 12.2140 |
| 10-Day Moving Average | 10.1980 |
| Average True Range | 1.9076 |
| ADX | 21.8 |
| +DI | 28.0701 |
| -DI | 48.1914 |
| Chandelier Exit (Long, 3 ATRs ) | 13.7772 |
| Chandelier Exit (Short, 3 ATRs ) | 10.1128 |
| Upper Bollinger Band | 20.5585 |
| Lower Bollinger Band | 3.8695 |
| Percent B (%b) | 0.08 |
| BandWidth | 136.6383 |
| MACD Line | -1.2338 |
| MACD Signal Line | 0.0727 |
| MACD Histogram | -1.3064 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 6.0150 | ||||
| Resistance 3 (R3) | 6.0533 | 5.8267 | 5.8825 | ||
| Resistance 2 (R2) | 5.8267 | 5.6242 | 5.8075 | 5.8383 | |
| Resistance 1 (R1) | 5.5233 | 5.4991 | 5.6750 | 5.4850 | 5.7941 |
| Pivot Point | 5.2967 | 5.2967 | 5.3725 | 5.2775 | 5.2967 |
| Support 1 (S1) | 4.9933 | 5.0942 | 5.1450 | 4.9550 | 4.6459 |
| Support 2 (S2) | 4.7667 | 4.9691 | 4.7475 | 4.6017 | |
| Support 3 (S3) | 4.4633 | 4.7667 | 4.5575 | ||
| Support 4 (S4) | 4.4250 |
